Tag: Ezallor

As of late 2024, the brand-name medication Ezallor, including the unique Ezallor Sprinkle formulation, has been officially discontinued in the U.S.. This development means that patients previously prescribed Ezallor for managing high cholesterol will need to consult their healthcare provider to find a suitable alternative treatment.

First approved in 2018, Ezallor Sprinkle is a medication for adults used to manage lipid disorders. The medication's active ingredient is rosuvastatin, and its unique sprinkle-based design was specifically created to assist patients with swallowing difficulties, such as those in long-term care facilities.